Fundraising Fox
Comanche Biopharma
Concord, US · Founded 2020 · Delaware corporation · 33 employees on LinkedIn · 6 known investors
Find your way into Comanche Biopharma
Each arrow is one introduction. Sign up to fill in the first one.
Ask Scott Gottlieb to introduce you to Mike Young
You →Scott · together at Comanche Biopharma →Mike
Ask Jamie Chen to introduce you to Allison August
You →Jamie · together at Moderna →Allison
Sign up to find every way you can get introduced to Comanche Biopharma
- Your email: who you already know at Comanche Biopharma, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Comanche Biopharma team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women. It focuses on evidence-based therapies for life-threatening complications of pregnancy.
Founders & leadership
Comanche Biopharma was founded in 2020 by Mike Young and T Scott Johnson.
Board
Investors · 6
How we know: Atlas Venture's portfolio page · the company's own site · a partner's Signal profile · funding news · press coverage · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: GV (Google Ventures)'s portfolio page · the company's own site · a partner's Signal profile · funding news · press coverage · Not right? Tell us
How we know: Broadview Ventures's portfolio page · Not right? Tell us
How we know: F-Prime Capital's portfolio page · press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: a partner's Signal profile · funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements$73.6M disclosed across 2 of 3 rounds · 2021–2025
- Undisclosed amountSeries BFeb 2025Source ↗
▶$37.5MraisedJan 2024 · 7 investors · PharmaceuticalsRule 506(b)
- Ann TaylorDirector
- Brendan Bulik-SullivanDirector
- Muzammil MansuriDirector
- Allison AugustExecutive Officer
- Paul AntinoriExecutive Officer
- Allyson FelixDirector
- David GrayzelDirector
- Thomas Scott JohnsonExecutive Officer, Director
- Scott GottliebDirector
- Ketan PatelDirector
- Michael YoungExecutive Officer
- Offering amount
- $75M
- Amount sold
- $37.5M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$36.1MraisedMay 2023 · 7 investors · PharmaceuticalsRule 506(b)
- Arthur LevinDirector
- Brendan Bulik-SullivanDirector
- Muzammil MansuriDirector
- Paul AntinoriExecutive Officer
- Allison AugustExecutive Officer
- Ann TaylorDirector
- Clive MeanwellDirector
- Allyson FelixDirector
- Ketan PatelDirector
- Michael YoungExecutive Officer
- Thomas Scott JohnsonExecutive Officer, Director
- Offering amount
- $36.1M
- Amount sold
- $36.1M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Comanche Biopharma.
In the news
Frequently asked questions
- What does Comanche Biopharma do?
- Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women. It focuses on evidence-based therapies for life-threatening complications of pregnancy.
- Who founded Comanche Biopharma?
- Comanche Biopharma was founded by Mike Young, T Scott Johnson in 2020.
- Who are Comanche Biopharma's investors?
- Comanche Biopharma's investors include Atlas Venture, GV (Google Ventures), Broadview Ventures, F-Prime Capital, Lilly Asia Ventures, New Enterprise Associates (NEA).
- How much funding has Comanche Biopharma raised?
- Comanche Biopharma has disclosed $73.6M raised across 2 of its 3 known rounds.
- Where is Comanche Biopharma headquartered?
- Comanche Biopharma is headquartered in Concord, US.